Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates

被引:32
|
作者
Tramper-Stranders, G. A. [1 ]
van der Ent, C. K. [1 ]
Molin, S. [2 ]
Yang, L. [2 ]
Hansen, S. K. [2 ]
Rau, M. H. [2 ]
Ciofu, O. [3 ]
Johansen, H. K. [4 ,5 ]
Wolfs, T. F. W. [6 ]
机构
[1] Wilhelmina Childrens Hosp, Cyst Fibrosis Ctr, Univ Med Ctr Utrecht, Dept Paediat Resp Med, NL-3508 AB Utrecht, Netherlands
[2] Tech Univ Denmark, Infect Microbiol Grp, Ctr Syst Biol, DK-2800 Lyngby, Denmark
[3] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark
[4] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark
[5] Rigshosp, Danish CF Ctr, DK-2100 Copenhagen, Denmark
[6] Wilhelmina Childrens Hosp, Dept Paediat Infect Dis, Univ Med Ctr Utrecht, NL-3508 AB Utrecht, Netherlands
关键词
Chronic infection; cystic fibrosis; genotyping; Pseudomonas aeruginosa; virulence; III SECRETION; PULMONARY INFECTIONS; GENETIC ADAPTATION; DCTA GENE; COLONIZATION; VIRULENCE; STRAINS; MICROEVOLUTION; INACTIVATION; PATHOGEN;
D O I
10.1111/j.1469-0691.2011.03627.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Clin Microbiol Infect 2012; 18: 567574 Abstract Despite intensive eradication therapy, some CF patients with early Pseudomonas aeruginosa infection rapidly develop a chronic infection. To elucidate factors associated with this persistence, bacterial characteristics of early P. aeruginosa isolates were analysed that were either eradicated rapidly or persisted despite multiple antimicrobial treatments. Eighty-six early infection episodes were studied. First P. aeruginosa isolates from patients with eradication (36) or persistent infection (16) were included; isolates from patients with intermittent infection (34) were omitted from the study. Virulence assays, antimicrobial resistance, cytotoxicity and mutation frequencies were analysed in vitro. P. aeruginosa was genotyped by SNP-array. Transcriptomic profiles of two eradicated and two persistent strains were compared. Nineteen per cent of patients developed persistent infection; 42% achieved eradication. Secretion of virulence factors and mutation frequencies were highly variable among both eradicated and persistent isolates and were not different between the groups. Cytotoxicity was present in 57% of eradicated vs. 100% of persistent isolates (p <0.01). None of the isolates were resistant to antibiotics. The isolates were genotypically highly diverse. Multivariate analysis showed that in vitro determined bacterial characteristics could not predict persistence after first P. aeruginosa infection. Preliminary transcriptomic data showed increased expression of some genes related to a metabolic pathway. The early onset of chronic infection was not associated with (in vitro determined) bacterial characteristics only. Although the persistent isolates were more often cytotoxic, for the individual patient it was not possible to predict the risk of persistence based on bacterial characteristics. Unknown factors such as host-pathogen and pathogen-pathogen interactions should be further explored.
引用
收藏
页码:567 / 574
页数:8
相关论文
共 50 条
  • [21] Proteomic Identification of OprL as a Seromarker for Initial Diagnosis of Pseudomonas aeruginosa Infection of Patients with Cystic Fibrosis
    Rao, Aparna R.
    Laxova, Anita
    Farrell, Philip M.
    Barbieri, Joseph T.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (08) : 2483 - 2488
  • [22] Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis
    Ratjen, Felix
    CURRENT OPINION IN PULMONARY MEDICINE, 2006, 12 (06) : 428 - 432
  • [23] Of isolates and isolation:: Pseudomonas aeruginosa in adults with cystic fibrosis
    Geddes, DM
    LANCET, 2001, 358 (9281): : 522 - 523
  • [24] CAN TRANSMISIBLE STRAINS OF PSEUDOMONAS AERUGINOSA BE SUCCESSFULLY ERADICATED IN ADULTS WITH CYSTIC FIBROSIS?
    Gilchrist, F. J.
    France, M.
    Bright-Thomas, R.
    Doherty, C.
    Govan, J.
    Webb, K.
    Jones, A. M.
    PEDIATRIC PULMONOLOGY, 2011, : 308 - 308
  • [25] What Spanish consensus meant for the treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis in the initial lung infection?
    Prados, Concepcion
    Zamarron, Ester
    Giron, Rosa
    MEDICINA CLINICA, 2020, 154 (06): : 232 - 235
  • [26] FUNCTIONAL GENOMICS TO DECIPHER THE EMERGENCE OF MULTIRESISTANT PHENOTYPES IN PERSISTENT PSEUDOMONAS AERUGINOSA CYSTIC FIBROSIS ISOLATES
    Bianconi, I
    Piazza, S.
    Jousson, O.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S292 - S292
  • [27] Low Rates of Pseudomonas aeruginosa Misidentification in Isolates from Cystic Fibrosis Patients
    Kidd, Timothy J.
    Ramsay, Kay A.
    Hu, Honghua
    Bye, Peter T. P.
    Elkins, Mark R.
    Grimwood, Keith
    Harbour, Colin
    Marks, Guy B.
    Nissen, Michael D.
    Robinson, Philip J.
    Rose, Barbara R.
    Sloots, Theo P.
    Wainwright, Claire E.
    Bell, Scott C.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (05) : 1503 - 1509
  • [28] Serratiopeptidase Affects the Physiology of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
    Artini, Marco
    Vrenna, Gianluca
    Trecca, Marika
    Assanti, Vanessa Tuccio Guarna
    Fiscarelli, Ersilia Vita
    Papa, Rosanna
    Selan, Laura
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [29] Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients
    Wagner, T
    Soong, G
    Sokol, S
    Saiman, L
    Prince, A
    CHEST, 2005, 128 (02) : 912 - 919
  • [30] Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia
    Rees, Vanessa E.
    Lucas, Deanna S. Deveson
    Lopez-Causape, Carla
    Huang, Yuling
    Kotsimbos, Tom
    Bulitta, Jurgen B.
    Rees, Murray C.
    Barugahare, Adele
    Peleg, Anton Y.
    Nation, Roger L.
    Oliver, Antonio
    Boyce, John D.
    Landersdorfer, Cornelia B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)